BPC-157
Quick facts
- Researched for
- Tendon and ligament recovery, joint comfort, muscle recovery, gut problems and recovery after procedures
- Route or form
- Injection
- Evidence so far
- Mostly rat studies, under 30 people tested, and no clear answer on cancer risk.
- Not established
- Feeling better doesn't prove an injury healed, and few good trials were done in people.
- Commonly researched
- 250 to 1,000 mcg, once dailySet by our editorsSee every range
- Where to get it
- At our partner, US Precision Peptides.Go to Next step
By the Learn Peptides editorial team · Updated · How We Research
What people are researching it for
People are researching BPC-157 for tendon and ligament recovery, joint comfort, muscle recovery, gut problems, and recovery after procedures.
Support. Recover. Perform.
BPC-157 (Body Protection Compound-157) is a synthetic peptide composed of 15 amino acids
- What is BPC-157?
- Checklist: 15 amino acids
- How does it work?
- Not written out in this text version.
- Common research use cases
- Not written out in this text version.
- How it's used in research
- Route: Subcutaneous (most common)
- Route: Local (near injury)
- Route: Oral (often for GI research)
- Common dosing: 250 to 500 mcg per day
- Common dosing: 1 to 2 times daily
- Common dosing: Duration typically 4 to 8 weeks (varies by research goal)
- Often combined with: TB-500
- Often combined with: Physical therapy
- Often combined with: Training modification
- Often combined with: Other research peptides
- There is no standardized dose or protocol. Research use should be thoughtful, tracked, and adjusted based on individual response.
- What users report
- Keep in mind: Results vary widely
- Keep in mind: Not everyone responds
- Keep in mind: May help with symptoms, but long-term effects on tissue remodeling in humans are still unknown
- Key takeaway
- It's not a magic solution, but it shows real potential and is one of the most discussed peptides for a reason.
- The bottom line
- BPC-157 shows strong potential in research, especially for injury recovery and gut health, but more high-quality human studies are needed. Use only high-purity peptides, follow a research-focused approach, and set realistic expectations.
Reasons people look into BPC-157. An interest is not a promise that it works.
- Injury & recovery
- Gut health
- Cognitive & mood
- Immune support
Visual guides to three blends that contain BPC-157: GLOW, KLOW and Wolverine.
Blends that include BPC-157. A blend is its own product, with its own amounts.
Repair. Rejuvenate. Recover.
- What is the GLOW Stack?
- Vial illustrations: GHK-Cu 50 mg / BPC-157 10 mg / TB-500 10 mg, each labelled "Research Use Only"
- Checklist: Not an FDA-approved drug
- typically combines three research peptides
- How does it work?
- Sections: GHK-Cu; BPC-157; TB-500
- Common research use cases
- Not written out in this text version.
- How it's used in research
- Route: Subcutaneous (most common)
- Route: Local (near injury)
- Common blend: GHK-Cu: 50 mg
- Common blend: BPC-157: 10 mg
- Common blend: TB-500: 10 mg
- Common blend: (Variations are common)
- Typical duration: 4 to 8 weeks (common initial period)
- Typical duration: Some run longer based on goals
- There is no standardized dose or protocol. Research use should be thoughtful, tracked, and adjusted based on individual response.
- What users report
- Keep in mind: Results vary widely
- Keep in mind: Not everyone responds
- Keep in mind: May help with symptoms, but long-term effects are still unknown
- Key takeaway
- It's not a magic solution, but it has real potential and is one of the most discussed peptide combinations for a reason.
- The bottom line
- The GLOW Stack shows strong potential for skin, hair, collagen, and recovery support, but more high-quality human studies are needed. Use only high-purity peptides, follow a research-focused approach, and set realistic expectations.
Four peptides. Multiple pathways. A broader approach.
- What is the KLOW Stack?
- Checklist: Often supplied in an 80 mg blend (50:10:10:10)
- Vial illustrations: GHK-Cu 50 mg / BPC-157 10 mg / TB-500 10 mg / KPV 10 mg, each labelled "Research Use Only". The TB-500 in a KLOW vial is the TB-500 fragment.
- Checklist: Four complementary peptides
- How does it work?
- Sections: GHK-Cu; BPC-157; TB-500; KPV
- KPV sub-box: Anti-inflammatory (NF-κB pathway)
- Common research use cases
- Not written out in this text version.
- How it's used in research
- Route: Subcutaneous (and common)
- Route: Research protocols vary
- Route: Sometimes used individually or in combination
- Common blend: 80 mg total per vial
- Common blend: 50 mg GHK-Cu
- Common blend: 10 mg BPC-157
- Common blend: 10 mg TB-500
- Common blend: 10 mg KPV (ratios may vary by source)
- Typical research use: 1 to 2x per day
- Typical research use: Duration: 4 to 12 weeks (varies by goal)
- Typical research use: Often combined with proper nutrition, training, and recovery protocols
- There is no standardized dose or protocol. Research use should be thoughtful, tracked, and adjusted based on individual response.
- What users report
- Keep in mind: Results vary widely
- Keep in mind: Not everyone responds the same way
- Keep in mind: May help with symptoms, but long-term effects are still unknown
- Keep in mind: Use quality, independently tested products
- Key takeaway
- It's not a magic solution, but it may help you reach new goals by supporting multiple pathways in the body.
- The bottom line
- The KLOW Stack combines four peptides with complementary benefits. It may be a valuable research tool for people seeking multi-pathway support, but it's not risk-free. Use only high-purity peptides, follow a research-focused approach, and set realistic expectations.
BPC-157 + TB-500
- What is the Wolverine Stack?
- Checklist: Two complementary peptides
- How does it work?
- Sections: BPC-157; TB-500
- Common research use cases
- Not written out in this text version.
- How it's used in research
- Route: Subcutaneous (most common)
- Route: Local (near injury)
- Route: Oral (less common)
- Common dosing: BPC-157: 250 to 500 mcg per day
- Common dosing: TB-500: 1 to 2 mg per week
- Common dosing: Typical duration: 4 to 8 weeks (varies)
- Often combined with: Physical therapy
- Often combined with: Training modification
- Often combined with: Proper nutrition
- Often combined with: Other research peptides (e.g., GHK-Cu, KPV)
- There is no standardized dose or protocol. Research use should be thoughtful, tracked, and adjusted based on individual response.
- What users report
- Keep in mind: Results vary widely
- Keep in mind: Not everyone responds
- Keep in mind: May help with symptoms, but long-term tissue remodeling in humans is still unknown
- Key takeaway
- It's not a magic solution, but real-world reports suggest meaningful potential when used as part of a broader research and recovery strategy.
- The bottom line
- The Wolverine Stack (BPC-157 + TB-500) is one of the most discussed peptide combinations in the research community. It shows strong potential for tissue repair and recovery support, but more high-quality human studies are needed. Use only high-purity peptides, follow a research-focused approach, and set realistic expectations.
- Also printed on the image
- Vial illustrations: BPC-157 10 mg; TB-500 10 mg, each labelled "Research Use Only"
Many report less pain and faster recovery, but some get mood or gut trouble.
Community reports
Many people report less pain, easier movement, or faster-feeling recovery. Others notice little change, and some report mood or stomach problems.
What this is based on
- Animal researchUseful for understanding a research question, but not the same as evidence in people.
- Community reportsWhat people describe noticing. Not proof of cause.
- Industry perspectiveCommentary from practitioners and the industry, based on experience. Not a study.
- Learn Peptides explanationOur own plain-English summary of the sources. It is not a source itself.
Community reports
People mostly use BPC-157 for injury recovery (tendons, joints, and recovery after surgery), and many say it worked well, sometimes even surprising their doctor. It's also tried for gut problems and mood, but those reports are much more mixed.
Mostly animal studies on tissue and gut repair so far, with few in people.
Animal studies support several questions about tissue and gut repair. Human research is still very limited.
Feeling better doesn't prove an injury healed, and few good trials were done in people.
Feeling better does not prove an injury has fully healed. Most published evidence is not from controlled human trials.
Safety notes
Mood changes and digestive symptoms also appear in some reports.
- You have trouble breathing or wheezing, or your face, lips, tongue or throat swell.
- You get hives away from the injection site, or feel severely dizzy or faint.
For these signs, call 911 or your local emergency number.
- Stop and contact a doctor if there is an infection where you injected, or new bleeding or bruising. For an allergic reaction, use the signs above. Industry perspective
- Redness spreads, or heat, swelling or pain keeps growing where you injected.
- A lump keeps growing or does not go away, or you see pus or red streaks.
- You have a fever or chills, or feel sick all over.
- Cancer, now or in the past. It helps grow new blood vessels, which tumors also need. Practitioner commentary says to avoid it with active or recent cancer, or to talk with your oncologist first. No human study has shown whether it raises or lowers cancer risk.
- Anxiety, panic, bipolar or another mood condition. Some people report flat mood or anxiety while taking it, which went away after stopping. Practitioner commentary also notes rare cases of worse mood or depression.
- Blood thinners: BPC affects platelet function, so the cited commentary advises staying away. Industry perspective
- Pregnancy or breastfeeding: avoid, no data. Industry perspective
- Before surgery, stop it about 7 days ahead and restart 3 to 7 days after. Industry perspective
- Banned in sport at all times: BPC-157 is on the (WADA) 2026 Prohibited List. This matters if you compete in drug-tested sport. Industry perspective
- Injection site reactions (redness, swelling, bruising, itching) are usually from re-using the same site too often. Industry perspective
- Headache, lightheadedness, or fatigue can happen, usually from a blood-pressure-lowering effect via nitric oxide. Industry perspective
Questions to bring to your doctor
Only for the conditions this page cautions about. Bring this page with you.
- I have or had cancer. Should I avoid BPC-157, and what would you watch for?
- What mood changes on BPC-157 should make me stop and call you?
Shows ranges from a practitioner, our editors and people, each with its source.
Commonly researched ranges, and how they were measured.
Commonly researched range for BPC-157
250 to 1,000 mcg
once daily · Injection
Set by our editors
This leading range covers the practitioner ranges listed below, from general use up to the highest one.
All 5 ranges in our record
Each one is labeled with where it comes from. They are different ways of using BPC-157, not steps to follow in order.
Standard (general optimization)
Practitioner- Amount per dose
- 200 to 250 mcg
- How often
- Once daily
- Typical schedule
- Continuous, or 2-3 short maintenance blocks per year (4-8 weeks each)
- Route
- Injection
Active injury repair / athletic recovery
Practitioner- Amount per dose
- 250 to 500 mcg
- How often
- Once daily
- Typical schedule
- Not stated
- Route
- Injection
Tendon, ligament, muscle injury
Practitioner- Amount per dose
- 250 to 500 mcg
- How often
- Once daily
- Typical schedule
- 4-8 week course; optional 2-week loading phase at a higher dose, then taper down
- Route
- Injection
Post-surgical recovery
Practitioner- Amount per dose
- 250 to 500 mcg
- How often
- Once daily
- Typical schedule
- At least 4-6 weeks
- Route
- Injection
Significant chronic dysfunction (under physician guidance)
Practitioner- Amount per dose
- 500 to 1,000 mcg
- How often
- Once daily
- Typical schedule
- Not stated
- Route
- Injection
From our visual summary
Community reports
Community reports, from the Learn Peptides visual summary. These lines sit beside the ranges above and are not merged with them.
- Common dosing
- 250 to 500 mcg per day
- 1 to 2 times daily
- Duration typically 4 to 8 weeks (varies by goal)
There is no standard dose. Track how you respond, and change one thing at a time.
These ranges were last reviewed Sep 2026.
Check your syringe math with your own numbers.
A short peptide based on one the body makes, most often discussed for tissue repair.
BPC-157 is a short chain of , sometimes called Body Protection Compound, modeled on a sequence the body already produces. It's one of the most consistently discussed peptides for tissue repair, which is why it anchors more protocols than any other compound in this reference. It's typically discussed as a small injection.
People often pair these two for injury recovery. They are different compounds, so it helps to compare what people report, what studies show and the cautions for each.
Next step
US Precision Peptides
About product links
Purchases at US Precision Peptides help keep Learn Peptides free.